Hemorrhagic Stroke Clinical Trial
Official title:
A Randomized, Controlled, Double-blind, Multi-center Clinical Study of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
The purpose of this study is to assess the efficacy and safety of Shengdi Dahuang Decoction in the treatment of acute hemorrhagic stroke by the randomized, controlled, double-blind, multi-center trial design project.
The main purpose of the study is to observe the clinical efficacy and safety of Shengdi Dahuang Decoction in the treatment of acute hemorrhagic stroke. This project is funded by Science and Technology Commission of Shanghai Municipality and will be carried out in 5 hospitals. Investigators will recruit 464 participants who meet the inclusion criteria and agree to participate in the research. Participants will be randomly assigned into experimental or placebo group. Granules of Shengdi Decoction is the therapeutic drug used in the experimental group. Each pack of the test drug contains 15 grams of rehmannia and 5 grams of rhubarb. While for the placebo group, each pack contains 2% rehmannia and rhubarb. Participants will receive a follow-up observation in the following 90 days. Modified Rankin Scale score (mRS), the mortality rate on day 7 and day 90 after treatment, National Institute of Health Stroke Scale (NIHSS), expansion rate of hematoma, the degree of edema and the expressions of inflammatory indicators will be detected to evaluate the clinical efficacy of Shengdi Dahuang Decoction. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Completed |
NCT01573117 -
A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1)
|
Phase 2 | |
Completed |
NCT03292211 -
The Effect of Early Mobilization in Mild to Moderate Hemorrhagic Stroke
|
N/A | |
Not yet recruiting |
NCT06069973 -
Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
|
||
Not yet recruiting |
NCT05816213 -
Point-of-care Low-field MRI in Acute Stroke
|
||
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04534556 -
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
|
N/A | |
Recruiting |
NCT05440682 -
Connectivity in Cranioplasty
|
N/A | |
Completed |
NCT05121415 -
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
|
||
Terminated |
NCT02626377 -
Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté
|
N/A | |
Completed |
NCT01942031 -
Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)
|
N/A | |
Completed |
NCT01845350 -
Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients
|
Phase 1 | |
Recruiting |
NCT05865795 -
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
|
||
Completed |
NCT04612218 -
Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies
|
||
Recruiting |
NCT06134921 -
Effects of Transcranial Electrical Stimulation in Stroke Individuals
|
N/A | |
Recruiting |
NCT06190314 -
SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
|
||
Recruiting |
NCT05735405 -
Aerobic Exercise and Cognitive Training in Patients With Stroke
|
N/A | |
Recruiting |
NCT06107725 -
Maimonides Minocycline in Stroke Study
|
Phase 2/Phase 3 | |
Completed |
NCT05916885 -
Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients.
|
N/A |